TP53 and ovarian carcinoma: Recent studies showed that abnormal p53 IHC reliably identifies cases with TP53 mutation in ovarian carcinoma (100% specificity and 96% sensitivity) and in EC biopsies (94% specificity and 91% sensitivity)7,8.